2005
DOI: 10.1016/j.jchromb.2005.08.003
|View full text |Cite
|
Sign up to set email alerts
|

HPLC analysis of flavokavins and kavapyrones from Piper methysticum Forst.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
22
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 28 publications
2
22
0
Order By: Relevance
“…Similarly to previous quantitative studies of compounds from kava, we observed a high level of reproducibility of replicate extractions of material from individual kava sources [45]. Principal component analysis showed that replicate extractions from the same kava source are tightly clustered (Figure S1).…”
Section: Resultssupporting
confidence: 80%
“…Similarly to previous quantitative studies of compounds from kava, we observed a high level of reproducibility of replicate extractions of material from individual kava sources [45]. Principal component analysis showed that replicate extractions from the same kava source are tightly clustered (Figure S1).…”
Section: Resultssupporting
confidence: 80%
“…Generally, six kavalactones, desmethoxyyangonin, dihydrokawain, dihydromethysticin, kawain, methysticin, and yangonin, are the major components in kava root, accounting for ∼60% of the mass balance of the organic extract (26). Three chalcones, flavokawains A, B, and C, are minor components, accounting for ∼1% of the organic extract (57). Among the different components in kava, the kavalactones seem to be the most potent inhibitors against cytochrome P450s (58).…”
Section: Discussionmentioning
confidence: 99%
“…In Europe, it was used for the treatment of chronic inflammations of the urinary tract at the beginning of the twentieth century [6,7]. However, the consumption of kava has recently been reported to cause serious side effects such as hepatitis and acute liver failure [8][9][10][11]13] and, consequently, European and Canadian drug control authorities have withdrawn the registration of all herbal medicinal products containing kava preparations. The U.S. FDA advises hepatitis patients to get their doctor's advice before consuming kava [9,12].…”
Section: Introductionmentioning
confidence: 99%